Barrow Neurological Institute is the world's largest neurological disease treatment and research institution, and is consistently ranked as one of the best neurosurgical training centers in the United States. Founded in 1962, the main campus is located at 350 W. Thomas Road, Phoenix, Arizona.

During the past decade, Barrow Neurological Institute conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 40 clinical trials were completed, i.e. on average, 51.3% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 21 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barrow Neurological Institute" #1 sponsor was "St. Joseph's Hospital and Medical Center, Phoenix" with 12 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Barrow Neurological Institute" with 4 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Biogen" with 4 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 98 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barrow Neurological Institute" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "ALS Association" with 5 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 5 trials as a collaborator, "Massachusetts General Hospital" with 5 trials as a collaborator and "Alzheimer's Disease Cooperative Study (ADCS)" with 4 trials as a collaborator. Other collaborators include 146 different institutions and companies that were collaborators in the rest 134 trials.

According to Clinical.Site data, the most researched conditions in "Barrow Neurological Institute" are "Amyotrophic Lateral Sclerosis" (17 trials), "Alzheimer Disease" (9 trials), "Alzheimer's Disease" (8 trials), "Multiple Sclerosis" (8 trials) and "Epilepsy" (7 trials). Many other conditions were trialed in "Barrow Neurological Institute" in a lesser frequency.

Most popular intervention types in "Barrow Neurological Institute" are "Drug" (91 trials), "Device" (21 trials), "Other" (16 trials), "Procedure" (10 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Ocrelizumab" (4 trials), "Donepezil" (3 trials), "AMX0035" (2 trials) and "AVP-923" (2 trials). Other intervention names were less common.

The vast majority of trials in "Barrow Neurological Institute" are 149 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Barrow Neurological Institute". undefined are not yet recruiting, 24 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 85 completed trials in Barrow Neurological Institute, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Barrow Neurological Institute, 12 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 17 trials that are defined as “Not Applicable".

Barrow Neurological Institute has several departments that took part in Clinical trials: "St. Joseph's Hospital and Medical Center (SJHMC) - Barrow Neurological Institute (BNI) - The Gregory W. Fulton ALS and Neuromuscular Disease Center" - 4 trials, "Barrow Neurological Clinics At St Joseph'S Hospital & Medical Center, 500 West Thomas Road Suite 720" - 2 trials